Vericel Corp. (VCEL)

[commoncentsinvestor]

"Cardiovascular disease costs will exceed $1 Trillion by 2035
Nearly half of Americans will develop pre-existing cardiovascular disease conditions, analysis by RTI International shows"

https://www.rti.org/news/cardiovascular-disease-costs-will-exceed-1-trillion-2035

Not such good news for human beings, but maybe so for Ixmyelocel-T, and Vericel shareholders:

“The results of the ixCELL-DCM study, which we believe is the largest randomized cell therapy trial to treat congestive heart failure completed to date, demonstrated a statistically significant and clinically meaningful reduction in cardiac events in patients who received treatment with ixmyelocel-T compared to placebo,” said Dr. David Recker, Vericel’s chief medical officer. “We are very excited about these study results given the lack of treatment options for end-stage heart failure patients.”

http://www.streetinsider.com/Corporate+News/Vericel+(VCEL)+Announces+Ixmyelocel-T+Phase+2b+ixCELL-DCM+Met+Primary+Endpoint/11408148.html